Label-Free Enrichment of Circulating Tumor Cells (CTCs).

Facilitating rapid discovery and development of potentially predictive signatures with the most advanced view of immuno-oncology biology.

The pursuit of a cure has taken a decisive new turn. nCounter SPRINT represents the most affordable product variation of a powerful new technology that is changing the face of cancer research. You can now exploit the benefits of nCounter technology in your research.

Enabling High-Plex Expression Analysis and Reduces Hands-on Time as Compared to qPCR.

Don’t let sample volume limit your analytical aspirations. Detect DNA, RNA, and protein changes in a single assay to use less precious material and gather more informative data.

Quantify protein and gene expression in one experiment with nCounter® Vantage 3D™ Immune Assays. Our immune assays are designed to complement our 770-plex immune-focused mRNA panel for in-depth characterization of up to 800 total targets:

Complementary companion advanced analysis software for Nanostring nCounter.